Holding some sort of hedge against rising inflation is the single most important tactic an investor can implement heading into next year. Read More
Archive
Filter
Walgreens unveils a new “consumer-centric” healthcare strategy after years of focusing on stores. Read More
One thing the Fed cannot control is the price of oil, which closed above $80 a barrel this week for the first time in seven years. Read More
Regardless of your age, you need to plan for your retirement now, not later. Read More
Once given up for dead, the nuclear industry is in the midst of a surprising renaissance, which is great news for this uranium miner. Read More
Breakthroughs in biological drugs have enabled physicians to treat many diseases that have been resistant to conventional therapies. Read More
We are removing clean energy utility NextEra from our Income Portfolio due to deteriorating demographic and climatic conditions. Read More
Merck soars on COVID treatment while AbbVie suffers a temporary setback. Read More
We interview a top investment expert on our staff about his methodologies for consistently beating the market. Read More
A year ago, I raised our buy limit on NextEra Energy (NYSE: NEE) to $80 after the Florida utility split its stock four for one. I reasoned that the company could “use its stock as currency to execute an acquisition.” For NextEra to be able to continue growing its revenue… Read More